Medicines & vaccines · United States

Alnylam Pharmaceuticals

Pioneer of RNA-interference therapeutics, holding the first approved siRNA drugs (Onpattro, Amvuttra, Givlaari), which form a new therapeutic modality.

Headquarters
Cambridge, Massachusetts, United States · North America
Value chain
Medicines & vaccines(Products); also Research & IP
What that means
Develops and sells therapeutics under its own name: drugs, biologics, vaccines, cell and gene therapies and radiopharmaceuticals.
Founded
2002
Ownership
Listed
Listing
Nasdaq:ALNY on Google Finance
Website
alnylam.com
Relevance
High at its strongest, in Advanced Therapeutics, Vaccines & Medical Countermeasures

In 1 capability

Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.

  1. Biotechnology & Health Technologies · Design · listed #36 of 50

    Pioneer of RNA-interference therapeutics, holding the first approved siRNA drugs (Onpattro, Amvuttra, Givlaari), which form a new therapeutic modality.

    Relevance: RNAi therapeutics pioneer

    Source · en.wikipedia.org